What is the recommended dose of Teicoplanin (glycopeptide antibiotic) for treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Teicoplanin Dosing Recommendations

For standard infections, administer teicoplanin with a loading dose of 6 mg/kg every 12 hours for three doses, followed by 6 mg/kg once daily; for severe infections including endocarditis and septic arthritis, use 12 mg/kg every 12 hours for three doses, then 12 mg/kg once daily. 1, 2

Standard Dosing Algorithm

Loading Dose Phase

  • Standard infections: 6 mg/kg IV every 12 hours for three doses (total of three doses over 48 hours) 3, 1
  • Severe infections (endocarditis, septic arthritis, osteomyelitis): 12 mg/kg IV every 12 hours for three doses 3, 1, 2
  • The loading dose is critical and must not be skipped, as teicoplanin requires this to rapidly achieve therapeutic levels 1, 4

Maintenance Dose Phase

  • Standard infections: 6 mg/kg once daily 3, 1
  • Severe infections: 12 mg/kg once daily to achieve target trough concentrations ≥20 mg/L 3, 2, 5

Renal Function-Based Dosing Intervals

After the loading phase, adjust the dosing interval based on glomerular filtration rate (GFR):

  • GFR >90 mL/min: Administer every 24 hours 3, 1
  • GFR 50-90 mL/min: Administer every 24 hours 3, 1
  • GFR 10-50 mL/min: Administer every 48 hours 3, 6
  • GFR <10 mL/min: Administer every 72 hours 3, 6

Critical pitfall: The loading dose remains the same regardless of renal function—only the maintenance interval changes. 6

Special Clinical Situations

Hemodialysis Patients

  • Loading dose: 12 mg/kg 3, 6
  • Follow-up: 6 mg/kg on days 2 and 3 3, 6
  • Maintenance: 6 mg/kg once weekly 3, 6

CAPD Peritonitis

  • Intravenous route: Follow GFR <10 mL/min dosing (every 72 hours) 3, 6
  • Intraperitoneal route:
    • Week 1: 20 mg/L in each bag 3, 6
    • Week 2: 20 mg/kg every other bag 3, 6
    • Week 3: 20 mg/kg in night bag only 3, 6

Continuous Renal Replacement Therapy (CAVH/CVVH)

  • Follow dosing for GFR 10-50 mL/min (every 48 hours) 3, 6

Pediatric Dosing

  • Loading: 10 mg/kg every 12 hours for three doses 3, 1
  • Maintenance: 6-10 mg/kg every 24 hours 3, 1

Therapeutic Drug Monitoring

Routine monitoring is not required by the manufacturer, but specific situations mandate level checks: 3, 7

When to Monitor

  • S. aureus endocarditis or septic arthritis 3, 2
  • Major burns 3, 6
  • Intravenous drug users 3, 6
  • Rapidly changing renal function 3, 6
  • Combination therapy with aminoglycosides 3

Target Trough Concentrations

  • Standard infections: ≥10 mg/L 6, 4
  • Severe infections (endocarditis, septic arthritis): ≥20 mg/L 3, 2, 5

Evidence Quality Discussion

The most recent guidelines 1, 6, 2 consistently recommend the 6 mg/kg loading dose for standard infections and 12 mg/kg for severe infections. Research evidence supports that higher loading doses (12 mg/kg) achieve therapeutic levels more rapidly—90-100% of patients reached target concentrations by days 2-3 with 12 mg/kg versus only 16-18% with 6 mg/kg. 4

For endocarditis specifically, older trials demonstrated that 6 mg/kg monotherapy had suboptimal cure rates, but 12 mg/kg or combination therapy with aminoglycosides achieved comparable efficacy to vancomycin. 5, 8 A 2014 study showed that 600 mg daily (approximately 8-10 mg/kg for average adults) achieved therapeutic levels in 68% of patients without increased toxicity. 9

Common Pitfalls to Avoid

  • Inadequate loading: Failing to give three loading doses leads to delayed therapeutic levels regardless of renal function 6, 4
  • Underdosing severe infections: Using 6 mg/kg for endocarditis or septic arthritis when 12 mg/kg is required 3, 5
  • Incorrect interval adjustment: Not extending dosing intervals in renal impairment causes drug accumulation 6
  • Overlooking monitoring needs: Missing the need for therapeutic drug monitoring in high-risk situations leads to treatment failure 3, 2

References

Guideline

Teicoplanin Dosing Regimen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Teicoplanin Dosing Regimen for Severe Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A critical review of the dosage of teicoplanin in Europe and the USA.

International journal of antimicrobial agents, 1994

Guideline

Teicoplanin Dosing in Patients with Impaired Renal Function

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Comparative pharmacokinetics of teicoplanin and vancomycin.

Journal of chemotherapy (Florence, Italy), 2000

Research

Teicoplanin in the treatment of serious infection.

Journal of chemotherapy (Florence, Italy), 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.